Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Novo Nordisk AS (NOVO B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7441
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product portfolio includes new-generation insulins, modern insulins, human insulins, oral antidiabetic agents, diabetes devices and others. Novo Nordisk also offers biopharmaceuticals for treating haemostasis, human growth hormone products, hormone replacement therapy and other serious chronic diseases. With subsidiaries in Europe, North America, Asia, Latin America, Africa, Middle East and Australia, the company markets its products in several countries worldwide. Novo Nordisk is headquartered in Bagsvaerd, Denmark.

Novo Nordisk AS (NOVO B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Novo Nordisk AS, Medical Equipment, Deal Details 11
Venture Financing 11
Beta Bionics Raises up to USD50 Million in Series B Venture Financing 11
Partnerships 12
Roche Enters into Development Agreement with Novo Nordisk 12
Novo Nordisk Forms Partnership with Dexcom and Glooko 13
Novo Nordisk Enters into Agreement with Glooko 14
Novo Nordisk Enters into Agreement with IBM Watson Health 15
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 18
Equity Offering 19
NNIT Prices IPO for USD191 Million 19
Acquisition 21
Novo Nordisk Acquires Ziylo for USD800 Million 21
Novo Nordisk AS – Key Competitors 23
Novo Nordisk AS – Key Employees 24
Novo Nordisk AS – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 30
Strategy And Business Planning 30
Apr 18, 2018: Sempre Health and Novo Nordisk Partner to Improve Medication Costs for Patients With Diabetes 30
Financial Announcements 31
May 02, 2018: Novo Nordisk’s operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018 31
Feb 01, 2018: Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion (5% growth in local currencies) 32
Nov 01, 2017: Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017 33
Aug 09, 2017: Novo Nordisk increased reported operating profit by 8% in the first six months of 2017 34
May 03, 2017: Novo Nordisk increased reported operating profit by 10% in the first three months of 2017 35
Feb 02, 2017: Novo Nordisk increased adjusted operating profit by 6% in local currencies in 2016 36
Corporate Communications 37
Oct 15, 2018: Novo Nordisk appoints Ludovic Helfgott executive vice president Biopharm 37
Sep 20, 2018: Novo Nordisk to lay off 400 employees in Denmark and China 38
Aug 15, 2017: Changes in Novo Nordisk Executive Management 39
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 40
May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk 41
Mar 01, 2017: Change in Novo Nordisk Executive Management 42
Other Significant Developments 43
Aug 08, 2018: Novo Nordisk’s operating profit decreased by 8% in danish kroner and increased by 4% in local currencies in the first six months of 2018 43
Sep 26, 2017: Novo Nordisk Teams Up with HITLAB to Challenge Innovators to Develop Voice-Activated Technology for Diabetes Care with $75,000 in Prizes 44
Jul 12, 2017: Novo Nordisk and Glooko advance their digital health collaboration with launch of unique integrated app for improved diabetes management 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Novo Nordisk AS, Medical Equipment, Key Facts, 2017 2
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Deals By Market, 2012 to YTD 2018 9
Novo Nordisk AS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Beta Bionics Raises up to USD50 Million in Series B Venture Financing 11
Roche Enters into Development Agreement with Novo Nordisk 12
Novo Nordisk Forms Partnership with Dexcom and Glooko 13
Novo Nordisk Enters into Agreement with Glooko 14
Novo Nordisk Enters into Agreement with IBM Watson Health 15
Novo Nordisk Enters into Research Agreement with Massachusetts Institute of Technology 16
BioClinica Enters Into Agreement With NNIT For Clinical Trial Management System 17
Novo Nordisk Enters Into Co-Development Agreement With Oxford University 18
NNIT Prices IPO for USD191 Million 19
Novo Nordisk Acquires Ziylo for USD800 Million 21
Novo Nordisk AS, Key Competitors 23
Novo Nordisk AS, Key Employees 24
Novo Nordisk AS, Subsidiaries 25

List of Figures
Novo Nordisk AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Novo Nordisk AS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Novo Nordisk AS, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Novo Nordisk AS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Novo Nordisk AS, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emerald Resources NL (EMR):企業の財務・戦略的SWOT分析
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Analyticon Biotechnologies AG:企業の製品パイプライン分析2018
    Summary Analyticon Biotechnologies AG (Analyticon), a subsidiary of Analyticon Discovery GmbH, is a medical device company that develops, manufactures, and distributes diagnostic systems. The company provides products in the areas of urine diagnostics, clinical chemistry, coagulation, and hematology …
  • East-Central Iowa Rural Electric Cooperative:発電所・企業SWOT分析
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報
    Summary Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen t …
  • Monitise plc:企業のM&A・事業提携・投資動向
    Monitise plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Monitise plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Co-Diagnostics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • NGEx Resources Inc:企業の戦略・SWOT・財務情報
    NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report Summary NGEx Resources Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sumitomo Realty & Development Co., Ltd.
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Inspire Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Inspire Medical Systems Inc (Inspire) is a medical device company that manufactures and markets healthcare implants. The company provides implanted neurostimulation device. Its product is used for treatment of obstructive sleep apnea. Inspire uses neurostimulation technologies. The company’s …
  • Merit Medical Systems Inc (MMSI):医療機器:M&Aディール及び事業提携情報
    Summary Merit Medical Systems, Inc. (Merit Medical) offers a wide range of single-use medical devices for interventional and diagnostic procedures. The company’s products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolyti …
  • Continental Engineering Corporation:企業の戦略・SWOT・財務分析
    Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report Summary Continental Engineering Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Nanosonics Ltd (NAN)-製薬・医療分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Seminole Electric Cooperative, Inc.:発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Bureau Veritas SA:企業の戦略・SWOT・財務分析
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Unum Therapeutics Inc (Unum) is a cancer cell therapy company that discovers, develops, and commercializes novel antibody-coupled cellular immunotherapies. The company uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology for discovering and developing new cellular immunoth …
  • Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析
    Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Virginia Electric and Power Company:電力:M&Aディール及び事業提携情報
    Summary Virginia Electric and Power Company (Virginia Power), formerly Virginia Public Service Corporation, is a regulated energy utility that generates, transmits, and distributes electricity. It generates electricity from gas, nuclear, oil, coal, renewable, and biomass sources. The company also pr …
  • BioTime Inc (BTX):企業の財務・戦略的SWOT分析
    BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oceanteam ASA (OTS):企業の財務・戦略的SWOT分析
    Oceanteam ASA (OTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆